The security firm described it as a critical pre-authentication remote code execution vulnerability in Oracle Identity ...

Shares have lost gains from a September AI-fueled pop, and the company’s debt load is growing.

The company, founded by Larry Ellison in 1977, has today become a big AI player after its involvement in spearheading the U.S ...

Oracle’s stock has come well off its highs, but a Jefferies analyst says concentration and debt concerns are overblown.

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 39% bearish. Among these notable options, 37 are puts, totaling $3,134,623, and 116 are calls, amounting to ...

According to Benzinga Pro, Oracle Corp's peer group average for short interest as a percentage of float is 6.28%, which means ...

Oracle recruits tech workers to Nashville to fill 8,500 jobs at its new $2 billion campus near healthcare industry leaders.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

On Thursday, Oracle ORCL earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83. Please watch the ...

Since the end of October, companies returning relatively large amounts of cash to shareholders through dividends and buybacks ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Oracle Corp., the once stodgy database giant that’s borrowed tens of billions and tethered its fortunes to the artificial intelligence boom, is quickly emerging as the credit market’s barometer for AI ...